Skip to content

Contribution of G4 Structure to Alzheimer’s Disease and Tau Pathology

· 0 citations · 254 references

TL;DR

This dissertation explores the hypothesis that G4-forming nucleic acids represent a mechanistic link between cellular stress, RNA biology, and tau aggregation in AD and establishes G-quadruplexes as previously underappreciated regulators of tau biology and implicates RNA structure as an active contributor to AD pathogenesis.

Abstract

The occurrence of Alzheimer’s Disease (AD) is rapidly increasing as our global population ages. With the majority of therapeutic drugs in the last couple of decades failing clinical trials, new molecular targets are needed to combat the expected influx of new AD cases. AD pathogenesis is associated with abnormal protein aggregation, characterized in part by intracellular accumulation of hyperphosphorylated tau (p-tau) in neurofibrillary tangles (NFTs). RNA has been identified as a major non-proteinaceous component of NFTs and has been implicated as an active cofactor in tau aggregation and spread. Recent work has shown that aggregates from AD brains contain almost double the amount of RNA as healthy individuals. This aggregate RNA is significantly enriched in polyguanine stretches with a high likelihood of forming G-quadruplexes (G4s). However, direct interactions between tau protein and G4 structures have been mostly unexplored. In this dissertation, I explore the hypothesis that G4-forming nucleic acids represent a mechanistic link between cellular stress, RNA biology, and tau aggregation in AD. We show that rG4 accumulation increases in the hippocampus with both age and with AD severity. We further observed that neurons exhibiting phospho-tau tangles also contained rG4 structures and that rG4 staining density varied with APOE genotype in the human tissue examined. We then explore the mechanism behind G4 tau interactions with physiological G4s from hippocampal aggregates. We found these G4s to be powerful, sequence-specific modulators of aggregation compared to other RNAs. These G4s induced unique biophysical properties and modulated solubility of associated proteins. They propagated aggregate spread in cells, stabilized distinct tau oligomer populations in the absence of exogenous seeds, and induced fibril formation to vastly differing lengths and morphologies with relatively small changes in nucleotide sequence. These results suggest that the complex systems driving protein aggregation and structural changes in cells could be due to differential enrichment of nucleic acids in aggregates. This work establishes G-quadruplexes as previously underappreciated regulators of tau biology and implicates RNA structure as an active contributor to AD pathogenesis.

View source

Similar papers

Review Aug 2026

HMGB1 signalling in Alzheimer's disease: pathogenic roles and therapeutic prospects.

High mobility group box 1 (HMGB1) is a crucial modulator of neuroinflammation in AD, according to new research, and a viable treatment approach for reducing neuroinflammation and associated pathologies with AD is to target HMGB1-mediated signalling networks.

Prashant Tyagi, Sneha Kumari, Prajjwal Sharma et al. · 1 citation
Open access Aug 2026

Investigating the role of EFhd2 protein in modulating tau pathology in a tauopathy mouse model

Findings indicate that Efhd2 deletion is associated with a shift in tau species toward earlier conformational states alongside reduced markers of later-stage aggregation, and suggest that EFhd2 may function as a modulatory component within a broader protein network influencing tau pathology.

Ahlam S. Soliman, Andrew Umstead, Irving E. Vega · 0 citations
Review Aug 2026

Tau dysfunction in alzheimer’s disease: molecular and cellular mechanisms, genetic modulation, and therapeutic perspectives

Findings support a model in which tau dysfunction results from the convergence of molecular aberrations and genetic susceptibility within a pathological network involving amyloid-β, neuroinflammation, and synaptic failure.

S. Sura, S. Jagadeesan, M. A. M. Moklas et al. · 0 citations
Review Open access Jul 2026

Mechanisms and Intervention Strategies of Beta-Amyloid and Tau Proteins in Alzheimer's Disease

The synergistic pathological network between Aβ and tau is clarified, updated progress on targeted therapies are summarized, and theoretical support for accurate early diagnosis and individualized clinical treatment of AD is offered.

Kexin Liu · 0 citations
Review Open access Aug 2026

Multi Target Directed Ligand for Alzheimer’s Disease: A Review of Therapeutic Strategies and Advances

Progress in the creation and design of Multi-target directed ligands have become a promising approach in the last few years, and recent advances in medicinal chemistry and structure-based design bolster the argument for MTDLs as next-generation therapeutic candidates, notwithstanding challenges like bioavailability and...

Sumesh Kumar, Vansh Sharma, Happy et al. · 0 citations
Review Open access Jul 2026

The molecular and genetic view of tauopathies: From structural polymorphism to systemic neurodegeneration

A holistic perspective is provided by synthesizing recent developments in the molecular and genetic architecture of tauopathies, particularly newly discovered genetic risk loci and cellular proteostasis mechanisms to analytically evaluate the diagnostic value of fluid biomarkers and current data on next-generation clin...

E. Ünal, S. Çomoğlu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.